Richard Godfrey, CEO of BerGenBio, received the award at the Nordic Life Science Days in Stockholm.
– I am honoured to receive this award on behalf of the company in recognition of the potential our innovative cancer drugs hold for patients, says Richard Godfrey to bergento.no.
Nordic Stars Awards were introduced in 2013 in special recognition of life science companies in the Nordic region demonstrating outstanding innovation and entrepreneurial skills.
This is how the jury explain the selection of BerGenBio:
“Norwegian BerGenBio’s commitment to develop companion diagnostics and first-in-class drugs targeting the cellular processes that make cancer cells immune-evasive, drug resistant and metastatic is a great example of what the future might hold. With focus on ground-breaking therapies and precision medicine BerGenBio is a leading example and a Nordic Star!”
– Our scientists are proud to be named Nordic Stars for their life science innovation – and full credit is due to them for the years of dedicated work needed to bring our first-in-class cancer drugs to patients in our clinical trials in Bergen, Germany and USA. And of course none of this would be possible if not for the continued support by our loyal stakeholders – thank you, says Godfrey.
BerGenBio was established in 2007 by Bergen Teknologioverføring AS, Unifob and researchers from the Institute of Biomedicine at the University of Bergen. The company is currently valued at 300 mNOK.
BerGenBio shared the award with the swedish company Amra and finnish company NexStim.
– This year’s winner of the Nordic Stars Awards are clearly future-oriented and committed to working in new ways to bring medical innovations to patients. They are both role models for others and an example of the innovation capacity in the life sciences in the Nordic countries, stated Jonas Ekstrand, Director General SwedenBIO.
Nordic Life Science Days in Stockholm, which set a new record for attendance, with over 1000 delegates from 31 countries, has established itself as the premier Nordic life sciences event.
You can read more about BerGenBio here
Main picture: (from left) Tommy Johansson (CEO Amra), Richard Godfrey (CEO BerGenBio) and Mikko Karvinen (CFO Nexstim). Photo: Camille Sonally.